Literature DB >> 2247653

Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation.

E Gluckman1.   

Abstract

Fanconi anemia is characterised by pancytopenia, malformations and chromosomal breaks probably related to a congenital defect of DNA repair mechanisms. The evolution is always fatal unless, the patient receives a bone marrow transplant from an HLA identical sibling. According to preliminary work on sensitivity of FA cells to alkylating agents and to in vivo radiosensitivity tests, we used a modified conditioning regimen with cyclophosphamide 20 mg/kg and 5 Grays thoraco-abdominal irradiation. Nineteen patients are reported. The actuarial survival is 74% with a median follow-up time of 4 years (range 6 months to 6 years). GVH was the main complication (58%). It was responsible directly or indirectly for 4 deaths. These results show that BMT in FA is successful in the large majority of cases. The decrease of the dose cyclophosphamide allowed a good engraftment without major toxicity. Studies are in progress for using this type of protocol in situations without a HLA matched sibling donor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2247653     DOI: 10.1016/0167-8140(90)90182-v

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

2.  Effects of an inadvertent dose of cytarabine in a child with Fanconi's anemia: reducing medication errors.

Authors:  Michael E Trigg; Vinay Nadkarni; Aaron Chidekel; Charles McKay; Rita Meek; Gregory Griffin; Maureen Edelson; Anne Reilly; Joseph Peoples; Stuart Levine; Frederick Meier
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Cord blood transplantation for bone marrow failure syndromes: state of art.

Authors:  Simona Pagliuca; Annalisa Ruggeri; Régis Peffault de Latour
Journal:  Stem Cell Investig       Date:  2019-12-05

4.  Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.

Authors:  Ramune Reliene; Mitsuko L Yamamoto; P Nagesh Rao; Robert H Schiestl
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

5.  Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy.

Authors:  L Murillo-Sanjuán; J Balmaña; A de Pablo García-Cuenca; J Lorente Guerrero; M L Uria Oficialdegui; E Carrasco; C Diaz-de-Heredia
Journal:  Clin Transl Oncol       Date:  2021-08-21       Impact factor: 3.405

6.  A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts.

Authors:  Sarah L Donahue; Colin Campbell
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

7.  FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions.

Authors:  Verena M Kuhnert; Lisa A Kachnic; Li Li; Martin Purschke; Liliana Gheorghiu; Richard Lee; Kathryn D Held; Henning Willers
Journal:  Int J Radiat Biol       Date:  2009-06       Impact factor: 2.694

Review 8.  Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment.

Authors:  J E Scaife; G C Barnett; D J Noble; R Jena; S J Thomas; C M L West; N G Burnet
Journal:  Br J Radiol       Date:  2015-05-26       Impact factor: 3.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.